Oracle Alpha »

Vertex Pharmaceuticals Incorporated shares owned by Oracle Alpha

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Oracle Alpha from 13F filings

Historical chart of Oracle Alpha investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Oracle Alpha consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Oracle Alpha

Quarter filed Position value Share count Share price at filing
2024-03-31 $480k 1.1k 418.01
2023-12-31 $354k 870 406.89

More positions owned by Oracle Alpha

Micron Technology (MU)
Coinbase Global (COIN)
Eli Lilly & Co. (LLY)
Intel Corporation (INTC)
NVIDIA Corporation (NVDA)
Macy's (M)
Samsara (IOT)
Applied Materials (AMAT)
Synchrony Financial (SYF)
Gitlab (GTLB)
Ptc Therapeutics I (PTCT)
Netflix (NFLX)
Johnson & Johnson (JNJ)
Regeneron Pharmaceuticals (REGN)
Thermo Fisher Scientific (TMO)

View all positions for Oracle Alpha

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
Morgan Stanley
FMR
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated